According to an article via South Bend Tribune, “Eli Lilly & Co. reported Wednesday that an experimental medication might slow mild Alzheimer’s if people take it early enough, one of a handful of drugs in late-stage testing in the frustrating hunt for a better treatment.” For more details, please visit: http://www.southbendtribune.com/life/health/alzheimer-s-drug-may-slow-decline/article_20395e61-48ef-5aca-9e00-936be0c5904a.html
